We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.2B
AUM Growth
-$48.8M
Cap. Flow
-$39.7M
Cap. Flow %
-3.3%
Top 10 Hldgs %
45.64%
Holding
136
New
5
Increased
35
Reduced
40
Closed
3

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$2.35M
2
TMO icon
Thermo Fisher Scientific
TMO
+$2.02M
3
CI icon
Cigna
CI
+$1.29M
4
PGNY icon
Progyny
PGNY
+$845K
5
KFY icon
Korn Ferry
KFY
+$627K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20M
2
AMZN icon
Amazon
AMZN
+$11.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.35M
4
LH icon
Labcorp
LH
+$2.27M
5
PEP icon
PepsiCo
PEP
+$2M

Sector Composition

Rank Sector Weight
1 Technology 44.34%
2 Healthcare 15.66%
3 Communication Services 15.45%
4 Consumer Discretionary 10.79%
5 Financials 10.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUSA icon
126
Murphy USA
MUSA
$11.4B
$350K 0.03%
1,024
+160
+19% +$50.8K
THO icon
127
Thor Industries
THO
$4.06B
$332K 0.03%
3,490
THC icon
128
Tenet Healthcare
THC
$22.2B
$318K 0.03%
4,823
+1,623
+51% +$121K
CW icon
129
Curtiss-Wright
CW
$25.1B
$317K 0.03%
1,620
RVTY icon
130
Revvity
RVTY
$12.6B
$285K 0.02%
+2,572
New +$302K
ESAB icon
131
ESAB
ESAB
$5.37B
$254K 0.02%
3,618
PEP icon
132
PepsiCo
PEP
$196B
$228K 0.02%
1,346
-11,034
-89% -$2M
VTRS icon
133
Viatris
VTRS
$20.8B
$179K 0.01%
18,120
ABBV icon
134
AbbVie
ABBV
$465B
-14,823
Closed -$2M
PINC
135
DELISTED
Premier
PINC
-27,907
Closed -$772K
TRV icon
136
Travelers Companies
TRV
$81.1B
-1,403
Closed -$244K

Similar funds

Oak Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Oak Associates held 136 positions worth $1.2B, down 3.9% from $1.25B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $39.7M in Q3 2023, closing 3 positions and reducing 40 holdings. Its most notable exit was AbbVie, an estimated $2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Thermo Fisher Scientific worth $1.92M.

  • Oak Associates's largest Q3 2023 buy was Thermo Fisher Scientific: 3,791 shares worth $1.92M.
  • Oak Associates added most to PayPal in Q3 2023, an estimated $2.35M increase.
  • Oak Associates's biggest Q3 2023 reduction was Apple, cutting an estimated $20M.
  • Oak Associates fully exited AbbVie in Q3 2023, selling an estimated $2M.
  • Oak Associates's ten largest holdings make up 46% of its $1.2B portfolio in Q3 2023.
  • Oak Associates opened 5 new positions and closed 3 in Q3 2023.
  • Oak Associates's portfolio value fell 3.9% quarter-over-quarter to $1.2B.

Based on Oak Associates's 13F filing for Q3 2023, filed 13 Nov 2023.